Multicentric Study an Endoscopic Treatment of Digestive Neoplasia by Submucosal Dissection Evaluation of a New Water Jet System
- Conditions
- Stomach NeoplasmRectal NeoplasmIntestinal Neoplasm
- Interventions
- Procedure: endoscopic sub-mucosal dissection
- Registration Number
- NCT01910974
- Lead Sponsor
- Hôpital Edouard Herriot
- Brief Summary
safety evaluation of endoscopic sub-mucosal dissection with nestis enki2 system. This system is a new water jet system which allows to perform Endoscopic submucosal dissection with a bifunctional catheter (injection and cutting).
- Detailed Description
Evaluation of the ability of this system to have a complete resection of superficial tumors of the digestive tract (that is to say a resection with free lateral and deep margins without residual tumor tissue)
Evaluation of the ability of such system to inject a viscous macromolecular solution of glycerol (glycerol mix: Glycerol 10 %, Fructose 5 %, saline solution 0.9%)(27. Fujishiro M, Yahagi N, Kashimura K, et al. Comparison of various submucosal injection solutions for maintaining mucosal elevation during endoscopic mucosal resection. Endoscopy. 2004;36:579-583.)
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 80
- OVER 18 YEARS OLD
- PATIENTS AGREED WITH THE STUDY
- SCORE ASA 1 OR 2
- Patient recorded in a social safety organism
- patients presenting with superficial lesions with an endoscopic indication of resection
- under 18 years old
- Patients not agreed with the study
- pregnant women
- patient included in an another study
- medical treatments (radiotherapy, surgery endoscopis treatements) before the intervention
- coagulation disorders
- score asa over 3
- patients with another neoplasic lesion
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description endoscopic sub-mucosal dissection endoscopic sub-mucosal dissection -
- Primary Outcome Measures
Name Time Method SAFETY THAT IS TO SAY PERFORATION RATE AND delayed BLEEDING ONE 18 months inclusion duration is about 6 months the following period will be about 12 months so a total duration of 18 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
NESTIS
🇫🇷Lyon, Rhone Alpes, France